AWHL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AWHL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2025-05-23), Aspira Womens Health's current share price is $0.0592. Aspira Womens Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $2.35. Aspira Womens Health's Cyclically Adjusted PB Ratio for today is 0.03.
The historical rank and industry rank for Aspira Womens Health's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Aspira Womens Health's highest Cyclically Adjusted PB Ratio was 24.72. The lowest was 0.01. And the median was 1.90.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Aspira Womens Health's adjusted book value per share data for the three months ended in Mar. 2025 was $-0.002. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.35 for the trailing ten years ended in Mar. 2025.
The historical data trend for Aspira Womens Health's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspira Womens Health Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
18.18 | 5.85 | 1.20 | 1.21 | 0.28 |
Aspira Womens Health Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.99 | 0.52 | 0.30 | 0.28 | 0.04 |
For the Diagnostics & Research subindustry, Aspira Womens Health's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Womens Health's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Aspira Womens Health's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Aspira Womens Health's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 0.0592 | / | 2.35 | |
= | 0.03 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspira Womens Health's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:
For example, Aspira Womens Health's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2025 (Change) | * | Current CPI (Mar. 2025) |
= | -0.002 | / | 134.9266 | * | 134.9266 | |
= | -0.002 |
Current CPI (Mar. 2025) = 134.9266.
Aspira Womens Health Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201506 | 3.272 | 100.684 | 4.385 |
201509 | 6.379 | 100.392 | 8.573 |
201512 | 5.051 | 99.792 | 6.829 |
201603 | 3.707 | 100.470 | 4.978 |
201606 | 2.731 | 101.688 | 3.624 |
201609 | 1.805 | 101.861 | 2.391 |
201612 | 1.078 | 101.863 | 1.428 |
201703 | 1.749 | 102.862 | 2.294 |
201706 | 1.209 | 103.349 | 1.578 |
201709 | 1.480 | 104.136 | 1.918 |
201712 | 0.851 | 104.011 | 1.104 |
201803 | 0.310 | 105.290 | 0.397 |
201806 | 2.405 | 106.317 | 3.052 |
201809 | 1.932 | 106.507 | 2.448 |
201812 | 1.421 | 105.998 | 1.809 |
201903 | 0.722 | 107.251 | 0.908 |
201906 | 2.124 | 108.070 | 2.652 |
201909 | 1.824 | 108.329 | 2.272 |
201912 | 1.347 | 108.420 | 1.676 |
202003 | 0.817 | 108.902 | 1.012 |
202006 | 1.084 | 108.767 | 1.345 |
202009 | 2.098 | 109.815 | 2.578 |
202012 | 1.393 | 109.897 | 1.710 |
202103 | 7.025 | 111.754 | 8.482 |
202106 | 6.269 | 114.631 | 7.379 |
202109 | 5.152 | 115.734 | 6.006 |
202112 | 4.036 | 117.630 | 4.629 |
202203 | 2.909 | 121.301 | 3.236 |
202206 | 1.886 | 125.017 | 2.035 |
202209 | 1.347 | 125.227 | 1.451 |
202212 | 0.840 | 125.222 | 0.905 |
202303 | 0.099 | 127.348 | 0.105 |
202306 | -0.062 | 128.729 | -0.065 |
202309 | -0.064 | 129.860 | -0.066 |
202312 | -0.222 | 129.419 | -0.231 |
202403 | -0.110 | 131.776 | -0.113 |
202406 | -0.289 | 132.554 | -0.294 |
202409 | -0.155 | 133.029 | -0.157 |
202412 | -0.147 | 133.157 | -0.149 |
202503 | -0.002 | 134.927 | -0.002 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Aspira Womens Health (OTCPK:AWHL) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Aspira Womens Health's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Nicole Sandford | director | 12117 BEE CAVES RD BLDG 3, STE 100, AUSTIN TX 78738 |
Minh Hoang Merchant | officer: General Counsel & Secretary | 1210 AVONDALE ROAD, HILLSBOROUGH CA 94010 |
Torsten Hombeck | officer: Chief Financial Officer | 529 W 42ND ST #6V, NEW YORK NY 10036 |
Celeste Rachelle Fralick | director | 2801 MESA ROAD, LUBBOCK TX 79403 |
Veronica Gh Jordan | director | C/O ALBANY MOLECULAR RESEARCH, INC., 26 CORPORATE CIRCLE, ALBANY NY 12212-5098 |
Stefanie L. Cavanaugh | director | 1120 S CAPITAL OF TX HWY, BLDG 1, STE 300, AUSTIN TX 78746 |
Ellen O'connor Vos | director | C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980 |
Jack W Schuler | 10 percent owner | 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045 |
Ryan Thinh Phan | officer: CSO & COO | 327 CARLTON AVE, LOS GATOS CA 95032 |
Jannie Prestridge Herchuk | director | 6331 LAVENDALE AVE, DALLAS TX 75230 |
Winfred Parnell | director | 6734 TALMADGE LANE, DALLAS TX 75230 |
Marlene Mclennan | officer: Interim Chief Financial Office | 400 SOUTH AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401 |
Ruby Sharma | director | 24 ARNOLD DRIVE, PRINCETON JCT. NJ 08550 |
Robert D Auerbach | director | C/O THE COOPER COMPANIES, INC., SUITE 590, PLEASANTON CA 94588 |
Valerie Barber Palmieri | director, officer: President and CEO | 63 INDIAN LEDGE RD., MONROE CT 06468 |
From GuruFocus
By Marketwired • 12-03-2024
By ACCESSWIRE • 04-08-2025
By GuruFocus News • 02-15-2025
By ACCESSWIRE • 02-13-2025
By GuruFocus News • 11-13-2024
By Marketwired • 10-15-2024
By GuruFocus News • 10-09-2024
By ACCESSWIRE • 04-17-2025
By Marketwired • 10-23-2024
By ACCESSWIRE • 03-31-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.